单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Wuhan,Peoples R China华中科技大学同济医学院附属同济医院[2]Huazhong Univ Sci Technol,Tongji Med Coll,Tongji Hosp,Wuhan,Peoples R China华中科技大学同济医学院附属同济医院[3]Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou, Peoples R China河南省肿瘤医院[4]Shandong First Med Univ & Shandong Acad Med Sci, Tai An, Shandong, Peoples R China[5]Hunan Canc Hosp, Changsha, Peoples R China[6]Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China中山大学附属第一医院[7]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China[8]Tongji Hosp,Canc Biol Res Ctr,Key Lab,Minist Educ,Wuhan,Peoples R China肿瘤生物医学中心华中科技大学同济医学院附属同济医院妇产科学系妇科肿瘤[9]Natl Clin Res Ctr Canc, Natl Canc Ctr, Beijing, Peoples R China[10]Tongji Hosp,Canc Biol Res Ctr,Wuhan,Peoples R China肿瘤生物医学中心华中科技大学同济医学院附属同济医院妇产科学系妇科肿瘤
第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Wuhan,Peoples R China
推荐引用方式(GB/T 7714)：
Ma Guanchen,Zeng Shaoqing,Zhao Yingjun,et al.Development and validation of a nomogram to predict overall survival of epithelial ovarian cancer patients: a population-based study[J].GYNECOLOGIC ONCOLOGY.2022,166:S194-S195.
APA：
Ma, Guanchen,Zeng, Shaoqing,Zhao, Yingjun,Chi, Jianhua,Wang, Li...&Gao, Qinglei.(2022).Development and validation of a nomogram to predict overall survival of epithelial ovarian cancer patients: a population-based study.GYNECOLOGIC ONCOLOGY,166,
MLA：
Ma, Guanchen,et al."Development and validation of a nomogram to predict overall survival of epithelial ovarian cancer patients: a population-based study".GYNECOLOGIC ONCOLOGY 166.(2022):S194-S195
医学